Pathology and Classification of Mitral Valve Disease

  • Issam IsmailEmail author
  • Axel Haverich


Normal mitral valve function needs structural integrity and coordinated interaction among its structures including leaflets, annulus, chordae tendinae, papillary muscles, left atrium, and the left ventricle. Mitral stenosis and mitral regurgitation are lesions used to describe cardiac dysfunction caused by structural or functional abnormalities of the mitral valve. The purposes of this chapter are to: (1) present the causes of mitral valve disease, (2) describe the structural and functional abnormalities in mitral valve disease, (3) emphasize the pathphysiologic changes in mitral valve disease, and (4) describe classifications of surgical mitral valve disease.


Mitral Valve Mitral Regurgitation Infective Endocarditis Papillary Muscle Mitral Stenosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    World Health Organization. Rheumatic fever and rheumatic heart disease: report of a WHO Study Group. WHO Technical Report Series. 1988;764:1-58.Google Scholar
  2. 2.
    Stollermann GH. Rheumatogenic streptococci and autoimmunity. Clin Immunol Immonopathol. 1991;61:131-142.CrossRefGoogle Scholar
  3. 3.
    Korn D, DeSanctis RW, Sell S. Massive calcification of the mitral annulus. N Engl J Med. 1962;267:900.CrossRefPubMedGoogle Scholar
  4. 4.
    Arnett FC, Reveille JD. The genetics of lupus erythematosus. Rheum Dis Clin North Am. 1992;18:865-892.PubMedGoogle Scholar
  5. 5.
    Sherer Y, Gorstein A, Fritzler MJ, Schoenfeld Y. Autoantibody explosion in systemic lupus erythromatosus: more than 100 different antibodies found in SLE patients. Semin Arthritis Rheum. 2004;34:501-537.CrossRefPubMedGoogle Scholar
  6. 6.
    Schweizer W, Gloor F, Von B, et al. Carcinoid heart disease with left sided lesions. Circulation. 1964;29:253-257.PubMedGoogle Scholar
  7. 7.
    Chaowalit N, Connolly HM, Schaff HV, et al. Carcinoid heart disease with primary ovarian Carcinoid ovarian tumor. Am J Cardiol. 2004;93:1314-1315.CrossRefPubMedGoogle Scholar
  8. 8.
    Ferrans VJ, Roberts WC. The carcinoid endocardial plaque; an ultrastructural study. Hum Pathol. 1976;7:387-409.CrossRefPubMedGoogle Scholar
  9. 9.
    Modlin IM, Shapiro MD, Kidd M. Carcinoid tumors and fibrosis: an association with no explanation. Am J Gastroenterol. 2004;99:2466-2478.CrossRefPubMedGoogle Scholar
  10. 10.
    Shone JD, Sellers RD, Anderson RC, et al. The developmental complex of “parachute mitral valve” supravalvar ring of left atrium, subaortic stenosis, and coarctation of aorta. Am J Cardiol. 1963;11:714-725.CrossRefPubMedGoogle Scholar
  11. 11.
    Bano-Rodrigo A, Van Praagh S, Trwitzsch E, et al. Double-orifice mitral valve: a study of 27 postmortem cases with developmental, diagnostic and surgical considerations. Am Cardiol. 1988;61:152-160.CrossRefGoogle Scholar
  12. 12.
    Davachi F, Moller JH, Edward JE. Diseases of the mitral valve in infancy: an anatomic analysis of 55 cases. Circulation. 1971;43:565-579.PubMedGoogle Scholar
  13. 13.
    Moore P, Adatia I, Spevak PJ, et al. Severe congenital mitral stenosis in infant. Circulation. 1994;89:2099-2106.PubMedGoogle Scholar
  14. 14.
    Carpentier A, Branchini B, Cour JC, et al. Congenital malformations of the mitral valve in children: pathology and surgical treatment. J Thorac Cardiovasc Surg. 1976;72: 854-866.PubMedGoogle Scholar
  15. 15.
    Hygenholtz PG, Ryan TJ, Stein SW, et al. The spectrum of pure mitral stenosis. Am J Cardiol. 1962;10:773-784.CrossRefGoogle Scholar
  16. 16.
    Roberts WC. Morphologic aspects of cardiac valve dysfunction. Am Heart J. 1992;123:1610-1632.CrossRefPubMedGoogle Scholar
  17. 17.
    Choi BW, Bacharach SL, Barbour DJ, et al. Left ventricular systolic dysfunction: Diastolic filling characteristics and exercise cardiac reserve in mitral stenosis. Am J Cardiol. 1995;75:526-529.CrossRefPubMedGoogle Scholar
  18. 18.
    Fawzy ME, Hassan W, Stefadouros M, Moursi M, Elshaer F, Chaudhary MA. Prevalence and fate of severe pulmonary hypertension in 559 consecutive patients with severe rheumatic mitral stenosis undergoing mitral balloon valvotomy. J Heart Valve Dis. 2004;13:942-947. discussion 947–948.PubMedGoogle Scholar
  19. 19.
    Schwartz R, Myerson RM, Lawrence LT, et al. Mitral stenosis, massive pulmonary hemorrhage, and emergency valve replacement. N Engl J Med. 1966;275:755-758.CrossRefPubMedGoogle Scholar
  20. 20.
    Fenster MS, Feldman MD. Mitral regurgitation: an overview. Curr Probl Cardiol. 1995;20:193-280.CrossRefPubMedGoogle Scholar
  21. 21.
    Hansen DE, Sarris GE, Niczyporuk MA, et al. Physiologic role of the mitral apparatus in left ventricular regional mechanics, contraction synergy, and global systolic performance. J Thorac Cardiovasc Surg. 1989;97:521-533.PubMedGoogle Scholar
  22. 22.
    Roberts WC. Morphologic aspects of cardiac valve dysfunction. Am Heart J. 1992;123:1610-1632.CrossRefPubMedGoogle Scholar
  23. 23.
    Waller BF, Morrow AG, Maron BJ, et al. Etiology of clinically isolated, severe, chronic, pure, mitral regurgitation: Analysis of 97 patients over 30 years of age having mitral valve replacement. Am Heart J. 1982;104:276-288.CrossRefPubMedGoogle Scholar
  24. 24.
    Waller BF, Howard J, Fess S. Pathology of mitral valve stenosis and pure mitral regurgitation, part I. Clin Cardiol. 1994;17:330-336.CrossRefPubMedGoogle Scholar
  25. 25.
    Waller BF, Howard J, Fess S. Pathology of mitral valve stenosis and pure mitral regurgitation, part II. Clin Cardiol. 1994;17:395-402.CrossRefPubMedGoogle Scholar
  26. 26.
    Carpentier A. Cardiac valve surgery: the French correction. J Thorac Cardiovasc Surg. 1983;86:323-337.PubMedGoogle Scholar
  27. 27.
    Carpentier A, Chauvaud S, Fabiani J, et al. Reconstructive surgery of mitral valve incompetence: ten-year appraisal. J Thorac Cardiovasc Surg. 1980;79:338-348.PubMedGoogle Scholar
  28. 28.
    Kishon Y, Oh JK, Schaff HV, et al. Mitral valve operation in postinfarction rupture of a papillary muscle: immediate results and long-term follow-up in 22 patients. Mayo Clin Proc. 1992;67:1023-1030.PubMedGoogle Scholar
  29. 29.
    Le Feuvre C, Metzger JP, Lachurie ML, et al. Treatment of severe mitral regurgitation caused by ischemic papillary muscle dysfunction: Indications for coronary angioplasty. Am Heart J. 1992;123:860-865.CrossRefPubMedGoogle Scholar
  30. 30.
    Ngaage DL, Schaff HV. Mitral valve surgery in non-ischemic cardiomyopathy. J Cardiovasc Surg. 2004;45:477-486.Google Scholar
  31. 31.
    Hayek E, Gring CN, Griffin BP. Mitral valve prolapse. Lancet. 2005;365:507-518.PubMedGoogle Scholar
  32. 32.
    Nesta F, Leyne M, Yosefy C, et al. New locus for autosomal dominant mitral valve prolapse on chromosome 13: clinical insights from genetic studies. Circulation. 2005;112:2022-2030.CrossRefPubMedGoogle Scholar
  33. 33.
    Devereux RB. Recent developments in the diagnosis and management of mitral valve prolapse. Curr Opin Cardiol. 1995;10:107-116.CrossRefPubMedGoogle Scholar
  34. 34.
    Barlow JB, Pocock WA. Mitral valve prolapse, the specific billowing mitral leaflet syndrome, or an insignificant non-ejection systolic click. Am Heart J. 1979;97:277-285.CrossRefPubMedGoogle Scholar
  35. 35.
    Barth CW 3rd, Dibdin JD, Roberts WC. Mitral valve cleft without cardiac septal defect causing severe mitral regurgitation but allowing long survival. Am J Cardiol. 1985; 55:1229-1231.CrossRefPubMedGoogle Scholar
  36. 36.
    Rowe DW, Desai B, Bezmalinovic Z, et al. Two-dimensional echocardiography in double orifice mitral valve. J Am Coll Cardiol. 1984;4:429-433.CrossRefPubMedGoogle Scholar
  37. 37.
    Zile MR, Tomita M, Ishihara K, et al. Changes in diastolic function during development and correction of chronic left ventricular volume overload produced by mitral regurgitation. Circulation. 1993;87:1378-1388.PubMedGoogle Scholar
  38. 38.
    Braunwald E, Awe WC. The syndrome of severe mitral regurgitation with normal left atrial pressure. Circulation. 1963;27:29-35.PubMedGoogle Scholar
  39. 39.
    Cohn LH, Couper GS, Kinchla NM, Collins JJ Jr. Decreased operative risk of surgical treatment of mitral regurgitation with or without coronary artery disease. J Am Coll Cardiol. 1990;16:1575-1578.CrossRefPubMedGoogle Scholar
  40. 40.
    Aoyagi S, Oryoji A, Nishi Y, et al. Long-term results of valve replacement with the St Jude Medical valve. J Thorac Cardiovasc Surg. 1994;108:1021-1029.PubMedGoogle Scholar
  41. 41.
    Fiore AC, Barner HB, Swartz MT, et al. Mitral valve replacement: Randomized trial of St Jude and Medtronic Hall prostheses. Ann Thorac Surg. 1998;66:707-712.CrossRefPubMedGoogle Scholar
  42. 42.
    Akins CW, Carroll DL, Buckley MJ, et al. Late results with Carpentier- Edwards porcine bioprosthesis. Circulation. 1990;82:IV65-74.PubMedGoogle Scholar
  43. 43.
    Bernal JM, Rabasa JM, Lopez R, et al. Durability of the Carpentier–Edwards porcine bioprosthesis: role of age and valve position. Ann Thorac Surg. 1995;60:248-252.CrossRefGoogle Scholar
  44. 44.
    Santini F, Casali G, Viscardi F, et al. The CarboMedics prosthetic heart valve: Experience with 1084 implants. J Heart Valve Dis. 2002;11:121-126. discussion 27.PubMedGoogle Scholar
  45. 45.
    Corbineau H, Du Haut Cilly FB, Langanay T, et al. Structural durability in Carpentier Edwards standard bioprosthesis in the mitral position: a 20-year experience. J Heart Valve Dis. 2001;10:443-448.PubMedGoogle Scholar
  46. 46.
    Khan SS, Chaux A, Blanche C, et al. A 20-year experience with the Hancock porcine xenograft in the elderly. Ann Thorac Surg. 1998;66:35-39.CrossRefGoogle Scholar
  47. 47.
    Borger MA, Ivanov J, Armstrong S, et al. Twenty-year results of the Hancock II bioprosthesis. J Heart Valve Dis. 2006;15:49-55. discussion 55.PubMedGoogle Scholar
  48. 48.
    Cohn LH, Collins JJ Jr, DiSesa VJ, et al. Fifteen-year experience with 1678 Hancock porcine bioprosthetic heart valve replacements. Ann Surg. 1989;210:435-442.CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2010

Authors and Affiliations

  1. 1.Division of Cardiac, Thoracic, Transplantation, and Vascular SurgeryHannover Medical SchoolHannoverGermany

Personalised recommendations